Pilot Study of a Self-help Intervention for Depression in Patients With a Chronic Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by University of Edinburgh.
Recruitment status was  Recruiting
University of Stirling
Robert Gordon University
University of Glasgow
Chief Scientist Office of the Scottish Government
Information provided by:
University of Edinburgh
ClinicalTrials.gov Identifier:
First received: March 2, 2009
Last updated: April 7, 2010
Last verified: April 2010
A feasibility pilot trial of the self-help, "Cognitive behavioural therapy" based "Living Life to the Full" Materials for use by patients with diabetes type 2 and / or coronary heart disease.

Condition Intervention
Diabetes Mellitus Type 2
Coronary Heart Disease
Behavioral: Living Life to the Full

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pilot Study of a Practice Nurse Supported Psychological Self-help Intervention for Patients With Diabetes or Coronary Heart Disease and Co-morbid Depression

Resource links provided by NLM:

Further study details as provided by University of Edinburgh:

Primary Outcome Measures:
  • The obstacles to providing access and support to a generic online self help computerised cognitive behavioural therapy (CBT) programme for such patients. [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The proportion of patients would prefer or require a non−computerised treatment alternative to treatment (i.e. a book or DVD based form of the treatment). [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]
  • The uptake, satisfaction with and completion of the self help programme when promoted and supported by practice nurses. [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]
  • A change in depression (BDI-2), anxiety , social function (WASAS), quality of life (Euroqol 5D) or illness perception (IPQ-R) from participation in a self help programme. [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 49
Study Start Date: February 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Self-help CBT
A nurse supported self-help CBT intervention in addition to usual care.
Behavioral: Living Life to the Full
A nurse-supported, self-help, cognitive behavioural therapy with web, video and booklet formats.
Other Name: Five Areas
No Intervention: Usual care

Detailed Description:

Depressed mood is common in patients with chronic disease and physical disability. It adversely affects quality of life, adherence to treatment and clinical outcome. Depression is expensive to the person, their family, employers and society. Recent developments in the UK General Practitioners' Contract mean that patients with two chronic diseases (Coronary Heart Disease- CHD and Diabetes − DM) are routinely screened for depression using a simple screening tool. We propose a study using an existing self help intervention in the specific context of patients with mild to moderately severe depression identified in this way.

This RCT is the second phase of a 2 phase mixed methods study examining the feasibility of a Full RCT. The first involved focus group with patients and health practitioners.


Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Have had a diagnosis of diabetes mellitus type 2 and / or coronary heart disease.
  • Be aged 35 or over.
  • Be attending a participating primary care practice.
  • Have a depression severity scale rating indicating moderate to moderately severe depression, such as:Prime-MD-PHQ9 of 10-21; HADS-D of 8-15;BDI-2 of 23-44

Exclusion Criteria:

  • Unable to provide informed consent to participate
  • Already receiving psychological treatment for their depression
  • Have commenced treatment with an SSRI within the past 8 weeks
  • Likely to have difficulty communicating by telephone
  • Likely to have difficulty completing the forms and questionnaires
  • Have a serious physical disorder
  • Have a serious mental disorder
  • Express significant suicidal thoughts (PHQ9 or BDI-2 question 9 scoring >1)
  • Took part in an earlier related focus group
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00854984

Contact: Carina Hibberd, PhD +4401316509460 c.hibberd@ed.ac.uk

United Kingdom
Faculty of Health and Social Care, Garthdee Campus, Robert Gordon University Recruiting
Aberdeen, United Kingdom, AB10 7QG
Community Health Sciences, GP Section, University of Edinburgh Recruiting
Edinburgh, United Kingdom, EH8 9DX
Sponsors and Collaborators
University of Edinburgh
University of Stirling
Robert Gordon University
University of Glasgow
Chief Scientist Office of the Scottish Government
Principal Investigator: Margaret Maxwell, PhD University of Stirling
  More Information

No publications provided

Responsible Party: Dr Margaret Maxwell, University of Stirling
ClinicalTrials.gov Identifier: NCT00854984     History of Changes
Other Study ID Numbers: CZH/4/462  MREC: 08/H0405/39 
Study First Received: March 2, 2009
Last Updated: April 7, 2010
Health Authority: Scotland: Scottish Executive Health Department

Keywords provided by University of Edinburgh:
Coronary heart disease
Cognitive behavioural therapy

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Depressive Disorder
Diabetes Mellitus, Type 2
Heart Diseases
Myocardial Ischemia
Arterial Occlusive Diseases
Behavioral Symptoms
Cardiovascular Diseases
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Mental Disorders
Metabolic Diseases
Mood Disorders
Vascular Diseases

ClinicalTrials.gov processed this record on February 04, 2016